id | C00026478 |
---|---|
Name | Quinoline |
CAS RN | 91-22-5 |
Standard InChI | InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H |
Standard InChI (Main Layer) | InChI=1S/C9H7N/c1-2-6-9-8(4-1)5-3-7-10-9/h1-7H |
Phytochemical cluster | |
---|---|
KCF-S cluster | No. 4717 |
By standard InChI | CHEMBL14474 |
---|---|
By standard InChI Main Layer | CHEMBL14474 |
By LinkDB | C06413 |
---|
By CAS RN | C037219 |
---|
class name | count |
---|
family name | count |
---|---|
Diapheromeridae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Oreophoetes peruana | 173814 | Diapheromeridae | Metazoa |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL14474 |
CHEMBL729206
(1)
|
1 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL14474 |
CHEMBL1908087
(1)
|
0 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | CHEMBL14474 |
CHEMBL2354282
(1)
|
4 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL14474 |
CHEMBL1614458
(1)
|
0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | CHEMBL14474 |
CHEMBL1908085
(1)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL14474 |
CHEMBL1794483
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C037219 | 11332 |
ACOT7
ACH1 ACT BACH CTE-II LACH LACH1 RP1-120G22.10 hBACH |
acyl-CoA thioesterase 7 (EC:3.1.2.2) | quinoline analog results in increased expression of ACOT7 protein |
increases expression
|
protein |
18645022
|
C037219 | 199 |
AIF1
AIF-1 IBA1 IRT-1 IRT1 |
allograft inflammatory factor 1 | quinoline analog results in increased activity of AIF1 protein |
increases activity
|
protein |
18645022
|
C037219 | 8125 |
ANP32A
C15orf1 HPPCn I1PP2A LANP MAPM PHAP1 PHAPI PP32 |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A | quinoline analog results in decreased expression of ANP32A protein |
decreases expression
|
protein |
18645022
|
C037219 | 301 |
ANXA1
ANX1 LPC1 |
annexin A1 | quinoline analog results in increased expression of ANXA1 protein |
increases expression
|
protein |
18645022
|
C037219 | 302 |
ANXA2
ANX2 ANX2L4 CAL1H LIP2 LPC2 LPC2D P36 PAP-IV |
annexin A2 | quinoline analog results in increased expression of ANXA2 protein |
increases expression
|
protein |
18645022
|
C037219 | 689 |
BTF3
BETA-NAC BTF3a BTF3b NACB |
basic transcription factor 3 | quinoline analog results in decreased expression of BTF3 protein |
decreases expression
|
protein |
18645022
|
C037219 | 836 |
CASP3
CPP32 CPP32B SCA-1 |
caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) | quinoline analog results in increased cleavage of and results in increased activity of CASP3 protein |
increases activity
/ increases cleavage |
protein |
18645022
|
C037219 | 11335 |
CBX3
HECH HP1-GAMMA HP1Hs-gamma |
chromobox homolog 3 | quinoline analog results in decreased expression of CBX3 protein |
decreases expression
|
protein |
18645022
|
C037219 | 891 |
CCNB1
CCNB |
cyclin B1 | quinoline analog results in increased expression of CCNB1 protein |
increases expression
|
protein |
18645022
|
C037219 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | quinoline analog results in increased expression of CDKN1A protein |
increases expression
|
protein |
18645022
|
C037219 | 1026 |
CDKN1A
CAP20 CDKN1 CIP1 MDA-6 P21 SDI1 WAF1 p21CIP1 |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) | [quinoline analog results in increased expression of TP53 protein] which results in increased expression of CDKN1A protein |
increases expression
|
protein |
18645022
|
C037219 | 1029 |
CDKN2A
ARF CDK4I CDKN2 CMM2 INK4 INK4A MLM MTS-1 MTS1 P14 P14ARF P16 P16-INK4A P16INK4 P16INK4A P19 P19ARF TP16 |
cyclin-dependent kinase inhibitor 2A | quinoline analog results in decreased methylation of CDKN2A promoter |
decreases methylation
|
promoter |
19417133
|
C037219 | 1029 |
CDKN2A
ARF CDK4I CDKN2 CMM2 INK4 INK4A MLM MTS-1 MTS1 P14 P14ARF P16 P16-INK4A P16INK4 P16INK4A P19 P19ARF TP16 |
cyclin-dependent kinase inhibitor 2A | quinoline analog results in increased expression of CDKN2A mRNA |
increases expression
|
mRNA |
19417133
|
C037219 | 1029 |
CDKN2A
ARF CDK4I CDKN2 CMM2 INK4 INK4A MLM MTS-1 MTS1 P14 P14ARF P16 P16-INK4A P16INK4 P16INK4A P19 P19ARF TP16 |
cyclin-dependent kinase inhibitor 2A | quinoline analog results in increased expression of CDKN2A protein |
increases expression
|
protein |
19417133
|
C037219 | 55748 |
CNDP2
CN2 CPGL HsT2298 PEPA |
CNDP dipeptidase 2 (metallopeptidase M20 family) (EC:3.4.13.18) | quinoline analog results in increased expression of CNDP2 protein |
increases expression
|
protein |
18645022
|
C037219 | 7812 |
CSDE1
D1S155E RP5-1000E10.3 UNR |
cold shock domain containing E1, RNA-binding | quinoline analog results in increased expression of CSDE1 protein |
increases expression
|
protein |
18645022
|
C037219 | 1544 |
CYP1A2
CP12 P3-450 P450(PA) |
cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) | quinoline analog results in decreased activity of CYP1A2 protein |
decreases activity
|
protein |
15916432
|
C037219 | 1548 |
CYP2A6
CPA6 CYP2A CYP2A3 CYPIIA6 P450C2A P450PB |
cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) | CYP2A6 protein results in increased metabolism of quinoline |
increases metabolic processing
|
protein |
8824525
|
C037219 | 1571 |
CYP2E1
CPE1 CYP2E P450-J P450C2E |
cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) | CYP2E1 protein results in increased hydroxylation of quinoline |
increases hydroxylation
|
protein |
8824525
|
C037219 | 1786 |
DNMT1
ADCADN AIM CXXC9 DNMT HSN1E MCMT |
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [quinoline analog results in increased degradation of DNMT1 protein] |
decreases reaction
/ increases degradation |
protein |
19417133
|
C037219 | 1786 |
DNMT1
ADCADN AIM CXXC9 DNMT HSN1E MCMT |
DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) | quinoline analog results in increased degradation of DNMT1 protein |
increases degradation
|
protein |
19417133
|
C037219 | 1869 |
E2F1
E2F-1 RBAP1 RBBP3 RBP3 |
E2F transcription factor 1 | quinoline analog affects the expression of E2F1 protein |
affects expression
|
protein |
15450938
|
C037219 | 1937 |
EEF1G
EF1G GIG35 |
eukaryotic translation elongation factor 1 gamma | quinoline analog results in increased expression of EEF1G protein |
increases expression
|
protein |
18645022
|
C037219 | 1938 |
EEF2
EEF-2 EF-2 EF2 SCA26 |
eukaryotic translation elongation factor 2 | quinoline analog results in decreased expression of EEF2 protein |
decreases expression
|
protein |
18645022
|
C037219 | 2149 |
F2R
CF2R HTR PAR-1 PAR1 TR |
coagulation factor II (thrombin) receptor | quinoline analog binds to and results in decreased activity of F2R protein |
affects binding
/ decreases activity |
protein |
16380251
|
C037219 | 6624 |
FSCN1
FAN1 HSN SNL p55 |
fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | quinoline analog results in increased expression of FSCN1 protein |
increases expression
|
protein |
18645022
|
C037219 | 8880 |
FUBP1
FBP FUBP |
far upstream element (FUSE) binding protein 1 | quinoline analog results in decreased expression of FUBP1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 3191 |
HNRNPL
HNRPL hnRNP-L |
heterogeneous nuclear ribonucleoprotein L | quinoline analog results in decreased expression of HNRNPL protein |
decreases expression
|
protein |
18645022
|
C037219 | 79256 | quinoline analog results in decreased expression of HNRPD protein |
decreases expression
|
protein |
18645022
|
||
C037219 | 3678 |
ITGA5
CD49e FNRA VLA5A |
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | quinoline analog binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] |
affects binding
/ decreases activity |
protein |
16984141
|
C037219 | 3690 |
ITGB3
BDPLT16 BDPLT2 CD61 GP3A GPIIIa GT |
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | quinoline analog binds to and results in decreased activity of [ITGA5 protein binds to ITGB3 protein] |
affects binding
/ decreases activity |
protein |
16984141
|
C037219 | 3958 |
LGALS3
CBP35 GAL3 GALBP GALIG L31 LGALS2 MAC2 |
lectin, galactoside-binding, soluble, 3 | quinoline analog results in increased expression of LGALS3 protein |
increases expression
|
protein |
18645022
|
C037219 | 4000 |
LMNA
CDCD1 CDDC CMD1A CMT2B1 EMD2 FPL FPLD FPLD2 HGPS IDC LDP1 LFP LGMD1B LMN1 LMNC LMNL1 PRO1 |
lamin A/C | quinoline analog results in decreased expression of LMNA protein |
decreases expression
|
protein |
18645022
|
C037219 | 4000 |
LMNA
CDCD1 CDDC CMD1A CMT2B1 EMD2 FPL FPLD FPLD2 HGPS IDC LDP1 LFP LGMD1B LMN1 LMNC LMNL1 PRO1 |
lamin A/C | quinoline analog results in increased expression of LMNA protein |
increases expression
|
protein |
18645022
|
C037219 | 4048 |
LTA4H
|
leukotriene A4 hydrolase (EC:3.3.2.6) | quinoline analog results in increased expression of LTA4H protein |
increases expression
|
protein |
18645022
|
C037219 | 5604 |
MAP2K1
CFC3 MAPKK1 MEK1 MKK1 PRKMK1 |
mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) | quinoline results in decreased activity of MAP2K1 protein |
decreases activity
|
protein |
18393446
|
C037219 | 1326 |
MAP3K8
COT EST ESTF MEKK8 TPL2 Tpl-2 c-COT |
mitogen-activated protein kinase kinase kinase 8 (EC:2.7.11.25) | quinoline analog results in decreased activity of MAP3K8 protein |
decreases activity
|
protein |
16973359
|
C037219 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | quinoline analog inhibits the reaction [ZAK protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] |
decreases reaction
/ increases activity / increases phosphorylation / increases reaction |
protein |
15737997
|
C037219 | 5599 |
MAPK8
JNK JNK-46 JNK1 JNK1A2 JNK21B1/2 PRKM8 SAPK1 SAPK1c |
mitogen-activated protein kinase 8 (EC:2.7.11.24) | quinoline analog results in decreased phosphorylation of and results in decreased activity of MAPK8 protein |
decreases activity
/ decreases phosphorylation |
protein |
15737997
|
C037219 | 4292 |
MLH1
COCA2 FCC2 HNPCC HNPCC2 hMLH1 |
mutL homolog 1 | quinoline analog results in increased expression of MLH1 mRNA |
increases expression
|
mRNA |
19417133
|
C037219 | 10797 |
MTHFD2
NMDMC |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase (EC:3.5.4.9 1.5.1.15) | quinoline analog results in decreased expression of MTHFD2 protein |
decreases expression
|
protein |
18645022
|
C037219 | 4666 |
NACA
NACA1 |
nascent polypeptide-associated complex alpha subunit (EC:5.3.99.3) | quinoline analog results in decreased expression of NACA protein |
decreases expression
|
protein |
18645022
|
C037219 | 10135 |
NAMPT
1110035O14Rik PBEF PBEF1 VF VISFATIN |
nicotinamide phosphoribosyltransferase (EC:2.4.2.12) | quinoline analog results in increased expression of NAMPT protein |
increases expression
|
protein |
18645022
|
C037219 | 4831 |
NME2
NDKB NDPK-B NDPKB NM23-H2 NM23B PUF |
NME/NM23 nucleoside diphosphate kinase 2 (EC:2.7.4.6 2.7.13.3) | quinoline analog results in increased expression of NME2 protein |
increases expression
|
protein |
18645022
|
C037219 | 29789 |
OLA1
DOC45 GBP45 GTBP9 GTPBP9 |
Obg-like ATPase 1 | quinoline analog results in decreased expression of OLA1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 10606 |
PAICS
ADE2 ADE2H1 AIRC PAIS |
phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) | quinoline analog results in increased expression of PAICS protein |
increases expression
|
protein |
18645022
|
C037219 | 11333 |
PDAP1
HASPP28 PAP PAP1 |
PDGFA associated protein 1 | quinoline analog results in decreased expression of PDAP1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 5160 |
PDHA1
PDHA PDHCE1A PHE1A |
pyruvate dehydrogenase (lipoamide) alpha 1 (EC:1.2.4.1) | quinoline analog results in increased expression of PDHA1 protein |
increases expression
|
protein |
18645022
|
C037219 | 5465 |
PPARA
NR1C1 PPAR PPARalpha hPPAR |
peroxisome proliferator-activated receptor alpha | quinoline analog binds to and affects the activity of PPARA protein |
affects activity
/ affects binding |
protein |
17610302
|
C037219 | 5468 |
PPARG
CIMT1 GLM1 NR1C3 PPARG1 PPARG2 PPARgamma |
peroxisome proliferator-activated receptor gamma | quinoline analog binds to and affects the activity of PPARG protein |
affects activity
/ affects binding |
protein |
17610302
|
C037219 | 5573 |
PRKAR1A
ACRDYS1 ADOHR CAR CNC CNC1 PKR1 PPNAD1 PRKAR1 TSE1 |
protein kinase, cAMP-dependent, regulatory, type I, alpha (EC:2.7.11.1) | quinoline analog results in increased expression of PRKAR1A protein |
increases expression
|
protein |
18645022
|
C037219 | 11212 |
PROSC
|
proline synthetase co-transcribed homolog (bacterial) | quinoline analog results in increased expression of PROSC protein |
increases expression
|
protein |
18645022
|
C037219 | 5684 |
PSMA3
HC8 PSC3 |
proteasome (prosome, macropain) subunit, alpha type, 3 (EC:3.4.25.1) | quinoline analog results in decreased expression of PSMA3 protein |
decreases expression
|
protein |
18645022
|
C037219 | 5700 |
PSMC1
P26S4 S4 p56 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 | quinoline analog results in increased expression of PSMC1 protein |
increases expression
|
protein |
18645022
|
C037219 | 5705 |
PSMC5
S8 SUG-1 SUG1 TBP10 TRIP1 p45 p45/SUG |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 | quinoline analog results in increased expression of PSMC5 protein |
increases expression
|
protein |
18645022
|
C037219 | 5710 |
PSMD4
AF AF-1 ASF MCB1 Rpn10 S5A pUB-R5 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 4 | quinoline analog results in decreased expression of PSMD4 protein |
decreases expression
|
protein |
18645022
|
C037219 | 5713 |
PSMD7
MOV34 P40 Rpn8 S12 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 7 | quinoline analog results in increased expression of PSMD7 protein |
increases expression
|
protein |
18645022
|
C037219 | 5902 |
RANBP1
HTF9A |
RAN binding protein 1 | quinoline analog results in decreased expression of RANBP1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 5955 |
RCN2
E6BP ERC-55 ERC55 TCBP49 |
reticulocalbin 2, EF-hand calcium binding domain | quinoline analog results in decreased expression of RCN2 protein |
decreases expression
|
protein |
18645022
|
C037219 | 6240 |
RRM1
R1 RIR1 RR1 |
ribonucleotide reductase M1 (EC:1.17.4.1) | quinoline analog results in decreased expression of RRM1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 1992 |
SERPINB1
EI ELANH2 LEI M/NEI MNEI PI-2 PI2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 1 | quinoline analog results in increased expression of SERPINB1 protein |
increases expression
|
protein |
18645022
|
C037219 | 5268 |
SERPINB5
PI5 maspin |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 | quinoline analog results in increased expression of SERPINB5 protein |
increases expression
|
protein |
18645022
|
C037219 | 7078 |
TIMP3
HSMRK222 K222 K222TA2 SFD |
TIMP metallopeptidase inhibitor 3 | quinoline analog results in decreased methylation of TIMP3 promoter |
decreases methylation
|
promoter |
19417133
|
C037219 | 7078 |
TIMP3
HSMRK222 K222 K222TA2 SFD |
TIMP metallopeptidase inhibitor 3 | quinoline analog results in increased expression of TIMP3 mRNA |
increases expression
|
mRNA |
19417133
|
C037219 | 7078 |
TIMP3
HSMRK222 K222 K222TA2 SFD |
TIMP metallopeptidase inhibitor 3 | quinoline analog results in increased expression of TIMP3 protein |
increases expression
|
protein |
19417133
|
C037219 | 51311 |
TLR8
CD288 |
toll-like receptor 8 | quinoline analog results in increased phosphorylation of and results in increased activity of TLR8 protein |
increases activity
/ increases phosphorylation |
protein |
17868034
|
C037219 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | quinoline analog inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] |
decreases reaction
/ increases expression |
protein |
16973359
|
C037219 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | quinoline analog results in increased activity of TP53 protein |
increases activity
|
protein |
12082016
|
C037219 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | quinoline analog results in increased expression of TP53 protein |
increases expression
|
protein |
18645022
|
C037219 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | quinoline analog results in increased expression of TP53 protein mutant form |
increases expression
|
protein |
18645022
|
C037219 | 7157 |
TP53
BCC7 LFS1 P53 TRP53 |
tumor protein p53 | [quinoline analog results in increased expression of TP53 protein] which results in increased expression of CDKN1A protein |
increases expression
|
protein |
18645022
|
C037219 | 81567 |
TXNDC5
ENDOPDI ERP46 HCC-2 PDIA15 STRF8 UNQ364 |
thioredoxin domain containing 5 (endoplasmic reticulum) | quinoline analog results in decreased expression of TXNDC5 protein |
decreases expression
|
protein |
18645022
|
C037219 | 9948 |
WDR1
AIP1 NORI-1 |
WD repeat domain 1 | quinoline analog results in increased expression of WDR1 protein |
increases expression
|
protein |
18645022
|
C037219 | 4904 |
YBX1
BP-8 CSDA2 CSDB DBPB MDR-NF1 NSEP-1 NSEP1 YB-1 YB1 |
Y box binding protein 1 | quinoline analog results in decreased expression of YBX1 protein |
decreases expression
|
protein |
18645022
|
C037219 | 51776 |
ZAK
AZK MLK7 MLT MLTK MRK mlklak pk |
sterile alpha motif and leucine zipper containing kinase AZK (EC:2.7.11.25) | quinoline analog inhibits the reaction [ZAK protein promotes the reaction [Anisomycin results in increased phosphorylation of and results in increased activity of MAPK8 protein]] |
decreases reaction
/ increases activity / increases phosphorylation / increases reaction |
protein |
15737997
|
C037219 | 51776 |
ZAK
AZK MLK7 MLT MLTK MRK mlklak pk |
sterile alpha motif and leucine zipper containing kinase AZK (EC:2.7.11.25) | quinoline analog results in decreased activity of ZAK protein |
decreases activity
|
protein |
15737997
|
OMIM | preferred title | UniProt |
---|---|---|
#127750 | Dementia, lewy body; dlb |
P37840
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D006528 | C037219 | Carcinoma, Hepatocellular |
marker/mechanism
|
598648
|
|
D006390 | C037219 | Hemangioendothelioma |
marker/mechanism
|
598648
|
|
D006394 | C037219 | Hemangiosarcoma |
marker/mechanism
|
598648
|
|
D009362 | C037219 | Neoplasm Metastasis |
marker/mechanism
|
598648
|